Press Releases
-
Huateng Pharma Unveils Y-Shape PEG NHS for Enhanced Drug PEGylation
Huateng Pharma has launched Y-Shape PEG NHS, an advanced PEGylation solution that enhances protein drug development by improving water solubility and biocompatibility through efficient and selective modification of proteins.
Jul 21, 2024
-
‘Biolyst Scientific’ Announced as New Brand Name to Encompass EMS and Azer, Will Deepen Offerings to Clinical and Research Lab Customers
Biolyst Scientific today announced its new brand name, reflecting the integration of Electron Microscopy Sciences (EMS) and Azer Scientific.
Jul 22, 2024
-
PCR Biosystems Introduces Advanced Inhibitor-Tolerant qPCR Mixes for Superior Detection on Challenging Samples
PCR Biosystems, a leading developer of PCR reagents, have launched a range of advanced inhibitor-tolerant mixes for probe-based qPCR and 1-step RT-qPCR. Available in the Clara® and Air-Dryable product lines to help researchers that work challenging, inhibitor-rich samples.
Jul 22, 2024
-
Envision Pharma Group launches 4Sight to drive AI and technology performance in healthcare
One of the world's leading providers of technology solutions Envision Pharma Group has announced the launch of 4Sight, a new form of AI-enabled technology to unlock the full potential of data and insights in medical affairs.
Jul 16, 2024
-
BOC Sciences Chemistry Scholarship Program of 2024 Announced
BOC Sciences is pleased to announce its new Scholarship Program aimed at supporting college students pursuing degrees in chemistry-related fields. This prestigious scholarship awards $1,000 annually to help these aspiring chemists achieve their academic goals and make a difference in the scientific community.
Jul 17, 2024
-
Upperton Pharma Solutions Adds Large-Scale Processing following MHRA Approval at Nottingham Facility.
Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO), is pleased to announce the successful completion of a Medicines and Healthcare products Regulatory Agency (MHRA) inspection at its newly commissioned 50,000 sq ft development and GMP manufacturing facility in Nottingham, UK.
Jul 14, 2024
-
Avallano releases ProtocolCopilot™: Powering Clinical Research with AI-driven Protocol Assistance
Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.
Jul 15, 2024
-
AXSENDO CLINICAL LAUNCHES FLAGSHIP RESEARCH SITE IN HOUSTON
About Axsendo Clinical Research Axsendo Clinical Research is a national site network, bringing together top physician investigators, sponsors, and CROs to meet the needs of patients everywhere through greater access to live saving drug therapies and medical devices. ACR offers access to a wide range of facility types including dedicated research sites, surgery centers, specialties hospitals, and more. Learn more about ACR by visiting our website at www.AxsendoClinicalResearch.com ###
Jul 15, 2024
-
Oracle Advances Safety Case Management for Life Science Organizations
Oracle announced new capabilities in its AI-supported Oracle Argus and Safety One Intake solutions to help life science organizations meet evolving regulatory requirements and the rising volume of adverse event case workloads. With new enhancements designed to increase productivity, improve data privacy, and enhance reporting, users can more efficiently address dynamic, country-specific regulations and requirements, and speed the reliability and transparency of safety case management from clinical trials through post-marketing surveillance.
Jul 9, 2024
-
Synexa Life Sciences Enrols in My Green Lab Certification Program
Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program.
Jul 9, 2024
-
Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access.
Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access. One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments.
Jul 8, 2024
-
CPHI South East Asia opens as growth prospects outlined for pharmaceutical development in Vietnam, Thailand and Cambodia
-
ChargePoint Technology strengthens its global presence by establishing a localised team in India to support the growing pharma manufacturing market
-
Indica Labs Expands Availability of HALO Digital Pathology Solutions in Asia Pacific Region Including CE-IVDR Marked HALO AP® Platform
Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region.
Jul 1, 2024
-
Greenphire Launches Industry’s First Patient Experience Dataset Transforming Clinical Trial Planning and Providing a View Into the Patient Journey
Greenphire announced the launch of their new Patient Experience Dataset.
Jun 17, 2024
-
Greenphire Releases Latest Innovation in Site Payments Technology Following Multiyear Multimillion-Dollar Investment
Greenphire launched next generation capabilities within their Site Payments solution to reduce top challenges of site payments for clinical trials.
Jun 24, 2024
-
Univo IRB Launches First-of-Its-Kind Electronic IRB Submission Portal, OneVerse™
Univo IRB announced the launch of OneVerseTM — the industry’s first purpose-built, electronic platform that modernizes the IRB experience.
Jun 25, 2024
-
WCG and MRCT Center Form Task Force to Tackle Ethical Challenges in AI-Based Clinical Research
The task force will evaluate AI's use in various aspects of clinical trials, including protocol design, consent considerations, patient privacy and confidentiality, and participant recruitment. It will also evaluate AI when it is being studied as an investigational product for use in medical care.
Jun 25, 2024
-
CatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight Capital
-
Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation
Avallano has ann announced the appointment of Michael A. Ibara, PharmD., as Chief Strategy Officer (CSO).
Jun 25, 2024